Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T21:29:13.628Z.
Calculation as of: 2026-10-06T21:29:13.628Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 667dd3b64d3a271f66e92979ae52668ccbc7e2b5b2cdee7c8377401ac3ef4785
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Tectonic Therapeutic, Inc.
Market Cap
$422.86M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$422.72M
EV/Sales Ratio
0.52x
TTM Avg
0.79x
3Y Avg
1.08x
5Y Avg
1.82x
Market Cap
$419.87M
EV/Sales Ratio
2.54x
TTM Avg
12.93x
3Y Avg
8.88x
5Y Avg
40.79x
Market Cap
$426.51M
EV/Sales Ratio
5.05x
TTM Avg
7.75x
3Y Avg
10562.36x
5Y Avg
7002.77x
Market Cap
$418.95M
EV/Sales Ratio
5.37x
TTM Avg
3.64x
3Y Avg
6.44x
5Y Avg
16.19x
Market Cap
$416.27M
EV/Sales Ratio
8.93x
TTM Avg
9.19x
3Y Avg
12.86x
5Y Avg
31.40x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. (TECX) | $422.86M | N/A | N/A | N/A | N/A |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | 0.52x | 0.79x | 1.08x | 1.82x |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | 0.95x | 0.80x | 0.91x | 1.13x |
| Prothena Corporation plc (PRTA)vs › | $419.87M | 2.54x | 12.93x | 8.88x | 40.79x |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $426.51M | 5.05x | 7.75x | 10562.36x | 7002.77x |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | 5.37x | 3.64x | 6.44x | 16.19x |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | 8.93x | 9.19x | 12.86x | 31.40x |
| Rezolute, Inc. (RZLT)vs › | $415.98M | N/A | 0.85x | 0.85x | 0.85x |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | 4.95x | 5.63x | 5.15x | 4.77x |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
